Your browser doesn't support javascript.
loading
Depth of neutrophil nadir after first cycle of R-CHOP predicts outcome in diffuse large B-cell lymphoma - a nationwide population-based cohort study.
Clausen, Michael Roost; Ulrichsen, Sinna Pilgaard; Larsen, Thomas Stauffer; Poulsen, Christian B; Tojaga, Selma; Pedersen, Per Trøllund; Madsen, Jakob; Pedersen, Robert Schou; Josefsson, Pär Lars; Gørløv, Jette Sønderskov; Nørgaard, Mette; d'Amore, Francesco.
Afiliación
  • Clausen MR; a Department of Hematology , Aarhus University Hospital , Aarhus , Denmark.
  • Ulrichsen SP; b Department of Clinical Epidemiology , Aarhus University Hospital , Aarhus , Denmark.
  • Larsen TS; c Department of Hematology , Odense University Hospital , Odense , Denmark.
  • Poulsen CB; d Department of Hematology , Zealand University Hospital , Roskilde , Denmark.
  • Tojaga S; e Department of Hematology , Sygehus Lillebaelt , Vejle , Denmark.
  • Pedersen PT; f Department of Hematology , Sydvestjysk Sygehus , Esbjerg , Denmark.
  • Madsen J; g Department of Hematology , Aalborg University Hospital , Aalborg , Denmark.
  • Pedersen RS; h Department of Medicine , Hospitalsenheden Vest , Holstebro , Denmark.
  • Josefsson PL; i Department of Hematology, Herlev Hospital , Herlev , Denmark.
  • Gørløv JS; j Department of Hematology , Rigshospitalet , Copenhagen , Denmark.
  • Nørgaard M; b Department of Clinical Epidemiology , Aarhus University Hospital , Aarhus , Denmark.
  • d'Amore F; a Department of Hematology , Aarhus University Hospital , Aarhus , Denmark.
Leuk Lymphoma ; 60(8): 1950-1957, 2019 08.
Article en En | MEDLINE | ID: mdl-30668181
We investigated if survival was predicted by nadir neutrophil counts after the first cycle of R-CHOP in patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL). Neutrophil counts (109/L) were categorized in four grades in the nadir time frame. Prognostic indices and comorbidity levels were calculated and used to adjust the Cox regression model. Kaplan-Meier and Cox regression methods were used to estimate and compare survival. We identified 965 patients. Grade 4 neutropenia was present in 432 (45%). Grade 0 patients had a 5-year overall survival of 67%, grade 1-2: 78%, grade 3: 64%, and grade 4: 57%. Compared with grade 0 adjusted hazard ratios (HR) for death were: 0.77 (95% CI 0.49-1.21) for grade 1-2, 1.18 (95% CI 0.82-1.71) for grade 3, and 1.33 (95% CI 1.02-1.73) for grade 4. Grade 4 neutropenia after the 1st cycle of chemotherapy predicted inferior outcome compared with grade 0 and 1-2. Grade 1-2 neutropenia seemed to have superior outcome.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Linfoma de Células B Grandes Difuso / Recuento de Leucocitos / Neutrófilos Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Dinamarca

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Linfoma de Células B Grandes Difuso / Recuento de Leucocitos / Neutrófilos Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Dinamarca